1324PThe role of modulation of somatostatin analogues (SSAs) in association to peptide receptor radionuclide therapy (PRRT) after SSAs progression disease (PD) in advanced well-differentiated (WD) entero-pancreatic neuroendocrine tumours (EP-NETs). (23rd October 2018) - Prinzi, N; Seregni, E; Raimondi, A; Maccauro, M; Corti, F; Lo Russo, G; Nichetti, F; Torchio, M; Coppa, J; Peverelli, G; Pagani, F; Di Bartolomeo, M; et al.